Human papillomavirus: current and future RNAi therapeutic strategies for cervical cancer

HS Jung, N Rajasekaran, W Ju, YK Shin - Journal of clinical medicine, 2015 - mdpi.com
Human papillomaviruses (HPVs) are small DNA viruses; some oncogenic ones can cause
different types of cancer, in particular cervical cancer. HPV-associated carcinogenesis …

[PDF][PDF] Therapeutic startegies for human papillomavirus infection and associated cancers

AC Bharti, T Singh, A Bhat, D Pande… - Front Biosci (Elite …, 2018 - article.imrpress.com
Human papillomavirus (HPV) infection is linked to development of cancer of cervix, vagina,
vulva, penis, ano-genital and non-genital oro-pharyngeal sites. HPV being a sexually …

Chiral control

D Butler, N Iwamoto, N Svrzikapa, GL Verdine… - US Patent …, 2018 - Google Patents
The present invention relates to chirally controlled oligonucleotides, chirally controlled
oligonucleotide compositions, and the method of making and using the same. The invention …

Methods for the synthesis of functionalized nucleic acids

GL Verdine, N Iwamoto, DCD Butler - US Patent 9,605,019, 2017 - Google Patents
The present application, among other things, provides technologies, eg, reagents, methods,
etc. for preparing oligonucleotides comprising phosphorothiotriesters linkages, eg …

Method for the synthesis of phosphorus atom modified nucleic acids

T Wada, M Shimizu - US Patent 9,695,211, 2017 - Google Patents
US9695211B2 - Method for the synthesis of phosphorus atom modified nucleic acids - Google
Patents US9695211B2 - Method for the synthesis of phosphorus atom modified nucleic acids …

Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice

C Moriya, H Taniguchi, K Miyata, N Nishiyama… - …, 2017 - academic.oup.com
Pancreatic cancer is one of the most lethal types of cancer, with aggressive properties
characterized by metastasis, recurrence and drug resistance. Cancer stem cells are …

[HTML][HTML] Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer

H Taniguchi, D Hoshino, C Moriya, H Zembutsu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
PR domain zinc finger protein 14 (PRDM14) maintains stemness in embryonic stem cells via
epigenetic mechanisms. Although PRDM14 is elevated in several cancers, it is unclear if …

Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14‐specific chimeric siRNA/nanocarrier complex

H Taniguchi, Y Natori, Y Miyagi… - … Journal of Cancer, 2021 - Wiley Online Library
PRDM14 is highly expressed in several cancers but is not detected in normal tissues. It
confers cancer stem cell‐like properties, including chemoresistance and distant metastasis …

Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator

T Gemba, R Nagata, I Shiga - US Patent 10,144,933, 2018 - Google Patents
Solution The present invention relates to an adjuvant which com prises oligonucleotides
which comprise two to four sequences each represented by 5'-X, CpG X2-3'and has a length …

Chiral nucleic acid adjuvant having antitumor effect and antitumor agent

T Gemba, R Nagata, Y Torikai - US Patent 10,149,905, 2018 - Google Patents
Abstract wherein each nucleic acid at 3′ end and 5′ end of the oligonucleotide is S type
nucleic acid connected by phosphorothioate linkage, and wherein the oligonucleotide …